Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Coding Corner Question: August Coding Challenge

Staff  |  Issue: August 2012  |  August 8, 2012

A 43-year-old female established patient diagnosed with rheumatoid arthritis comes to the office for her first infliximab infusion. The rheumatologist reviews the results of her labs, chest X-ray, and PPD test that were done the week prior to her procedure. The PPD and chest X-ray are negative. She reports still having some pain, stiffness, and swelling in her elbows, wrists, and most of her finger joints. She denies any fevers, cough, dyspnea, or concurrent illness. She is on a nonsteroidal antiinflammatory drug, weekly methotrexate subcutaneous injections, folic acid, and ranitidine. The physician performs an expanded problem-focused exam. No changes are made to her medications.

She is administered 50 mg of diphenhydramine as a prophylactic against any reaction to the infliximab. Her IV port is started at 10 a.m. and 200 mg of intravenous infliximab infusion started at 10:15 a.m. The infusion ended at 12:25 p.m.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

How would you code this patient encounter?

click here for the answer.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Share: 

Filed under:Billing/CodingConditionsPractice SupportRheumatoid Arthritis Tagged with:anti-inflammatoryBillingCodingdrugimaginginfliximabPractice ManagementRheumatoid arthritisrheumatologist

Related Articles

    Dermatology Case Answer B: September

    September 18, 2013

    Foot rash on man with hypertension

    Hair dye being applied to a man’s beard.

    Case Report: A 50-Year-Old Man Suffers Dye-Induced Arthritis

    December 18, 2019

    Hair dye products are commonly used by both men and women to enhance youth and beauty and to follow fashion trends. As reported in the medical literature, hair dyes and their ingredients are associated with allergic contact dermatitis. A possible association with joint inflammation has also been recognized. There is literature to support that para-phenylenediamine…

    Rheumatology Drugs at a Glance, Part 3: Rheumatoid Arthritis

    August 16, 2019

    Jarun Ontakrai / shutterstock.com Over the past few years, bio­similars and other new drugs have been introduced to treat rheumatic illnesses. Some of the conditions we treat have numerous drug options, others have few or only off-label options. This series, “Rheumatology Drugs at a Glance,” provides streamlined information on the administration of biologic, biosimilar and…

    Coding Corner Question: September

    September 1, 2014

    Coding for first infliximab infusion in patient with rheumatoid arthritis

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences